Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TUBA1A Antibody (Phospho-Tyr272) | Login | TUBA1A Antibody (Phospho-Tyr272) | ||||||||||||||||
|
||||||||||||||||||
| TUBA1A Antibody - C-terminal region | Login | TUBA1A Antibody - C-terminal region | ||||||||||||||||
|
||||||||||||||||||
| USP38 Antibody - middle region | Login | USP38 Antibody - middle region | ||||||||||||||||
|
||||||||||||||||||
| TNFSF12 Antibody - middle region | Login | TNFSF12 Antibody - middle region | ||||||||||||||||
|
||||||||||||||||||
| WASF1 Antibody (Phospho-Tyr125) | Login | WASF1 Antibody (Phospho-Tyr125) | ||||||||||||||||
|
||||||||||||||||||
| WASF1 Antibody | Login | WASF1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| ZNF598 Antibody (Phospho-Tyr306) | Login | ZNF598 Antibody (Phospho-Tyr306) | ||||||||||||||||
|
||||||||||||||||||
| WTAP Antibody - C-terminal region | Login | WTAP Antibody - C-terminal region | ||||||||||||||||
|
||||||||||||||||||
| TNFSF15 Antibody - C-terminal region | Login | TNFSF15 Antibody - C-terminal region | ||||||||||||||||
|
||||||||||||||||||
| MED12 Antibody - middle region | Login | MED12 Antibody - middle region | ||||||||||||||||
|
||||||||||||||||||
| BUB1B-PAK6 Protein Lysate | Login | BUB1B-PAK6 Protein Lysate | ||||||||||||||||
|
||||||||||||||||||
| BUB1B-PAK6 Protein Lysate | Login | BUB1B-PAK6 Protein Lysate | ||||||||||||||||
|
||||||||||||||||||
| EEF1AKMT4-ECE2 Protein Lysate | Login | EEF1AKMT4-ECE2 Protein Lysate | ||||||||||||||||
|
||||||||||||||||||
| CCR2 ELISA Kit (Human) | Login | CCR2 ELISA Kit (Human) | ||||||||||||||||
|
||||||||||||||||||
| ANG2 ELISA Kit (Bovine) | Login | ANG2 ELISA Kit (Bovine) | ||||||||||||||||
|
||||||||||||||||||
| S100A11 ELISA Kit (Rabbit) | Login | S100A11 ELISA Kit (Rabbit) | ||||||||||||||||
|
||||||||||||||||||
| GAPDH ELISA Kit (Mouse) | Login | GAPDH ELISA Kit (Mouse) | ||||||||||||||||
|
||||||||||||||||||
| CD24 ELISA Kit (Human) | Login | CD24 ELISA Kit (Human) | ||||||||||||||||
|
||||||||||||||||||
| CD24 ELISA Kit (Human) | Login | CD24 ELISA Kit (Human) | ||||||||||||||||
|
||||||||||||||||||
| HLA-DQB1 ELISA Kit (Human) | Login | HLA-DQB1 ELISA Kit (Human) | ||||||||||||||||
|
||||||||||||||||||
| MCP1 ELISA Kit (Monkey) | Login | MCP1 ELISA Kit (Monkey) | ||||||||||||||||
|
||||||||||||||||||
| MIF ELISA Kit (Rat) | Login | MIF ELISA Kit (Rat) | ||||||||||||||||
|
||||||||||||||||||
| MIF ELISA Kit (Rat) | Login | MIF ELISA Kit (Rat) | ||||||||||||||||
|
||||||||||||||||||
| IL-17A/F ELISpot Assay Kit (Human) | Login | IL-17A/F ELISpot Assay Kit (Human) | ||||||||||||||||
|
||||||||||||||||||
| MMP13 ELISA Kit (Rat) | Login | MMP13 ELISA Kit (Rat) | ||||||||||||||||
|
||||||||||||||||||


